Verily and Johnson & Johnson‘s (NYSE:JNJ) collaborative business Verb Surgical looks to set the stage for a new style of robotic surgery, called “digital surgery,” according to an interview with CEO Scott Huennekens.
Verb Surgical aims to develop a comprehensive surgical platform that incorporates “leading edge” robotic capabilities and medical technology for use in the operating room, according to Johnson & Johnson. The company plans to develop them in partnership with surgeons and hospitals with a goal of “greater hospital efficiency.”
“First of all, we think of us not as a robotics company but as a surgical platform company,” Huennekens told MD&DI. “Instead of having robotics that is used in just 5% of procedures and its like a mainframe computer, we’re thinking of robotics like it’s a PC. It’s always there, it’s always on.”
Verb Surgical aims to shift the paradigm to make advanced robotic surgery platforms lower cost and more accessible, bringing together instruments, visualization and robotics along side decision making algorithms to create a “seamless solution,” Heunnekens said.